CHI-California Healthcare Institute and the HealthCare Institute of New Jersey (HINJ) will host a congressional briefing to facilitate a dialogue about Alzheimer’s disease research. This program will include an overview of advances stemming from California’s and New Jersey’s life sciences sectors, with an expert panel discussing current research and drug development, as well as future discoveries.
